unmet needs in the adjuvant setting for renal cell carcinoma
Published 10 years ago • 303 plays • Length 4:49Download video MP4
Download video MP3
Similar videos
-
7:08
unmet needs in kidney cancer
-
1:34
unmet needs in the treatment of renal cell carcinoma
-
4:15
the unmet needs of kidney cancer treatment
-
1:27
unmet needs regarding immunotherapy for renal cell carcinoma
-
1:21
dr. uzzo on unmet needs in kidney cancer
-
1:13
dr. mckay on unmet needs for rcc
-
2:53
unmet needs in systemic therapy for liver cancer
-
3:59
the future of renal cell carcinoma
-
7:18
vegf tki therapy in the adjuvant setting of rcc
-
0:43
dr. rini on adjuvant immunotherapy in renal cell carcinoma
-
2:37
key unmet needs in kidney cancer
-
4:48
unmet needs in rcc
-
1:25
dr. hsieh on unmet needs of rare kidney cancer variants
-
1:08
dr. mcgregor on unmet needs in non-clear cell rcc
-
6:50
adjuvant therapy in resected high-risk renal cell carcinoma
-
0:35
the latest developments in adjuvant therapy for rcc
-
2:00
dr. pal on adjuvant therapy of renal cell carcinoma
-
1:23
dr. mcgregor on unmet needs in advanced rcc
-
32:22
auau podcast: adjuvant therapy in renal cell carcinoma
-
1:35
dr. george on the use of adjuvant sunitinib in rcc
-
19:55
adjuvant sunitinib for high risk renal cell carcinoma: not ready for prime time
-
19:31
adjuvant therapy in high risk renal cell carcinoma
-
1:15
dr. voss on treatment in the neoadjuvant setting for kidney cancer
-
3:03
adjuvant pembrolizumab improves rcc disease-free survival | toni choueiri
-
3:47
other clinical trials in renal cell carcinoma
-
0:53
the role of icis in the adjuvant setting for rcc
-
2:18
dr. pal discusses adjuvant therapy for renal cell carcinoma
-
3:54
addressing unmet needs in mrcc
-
1:08
clinical trials in adjuvant rcc
-
1:03
dr. barocas on adjuvant sunitinib in renal cell carcinoma
-
44:07
advanced kidney cancer: what the urologist needs to know
-
2:16
dr. rini on axitinib for treatment of metastatic renal cell carcinoma
-
1:03
potential of adjuvant therapy for rcc
-
2:35
adjuvant therapy in rcc: harnessing prognostic information
-
1:00
adjuvant pembrolizumab in kidney cancer from keynote 564
-
5:33
keynote-564: pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for patients with...
-
5:16
potential new treatments in renal cell carcinoma
-
10:38
considerations for using adjuvant therapy in mrcc
-
5:56
recent data in the adjuvant setting of rcc
-
45:48
new developments in adjuvant therapy for renal cell carcinoma scott s. tykodi, m.d., ph.d.
-
3:01
a phase iii trial of pembrolizumab as adjuvant treatment for renal cell carcinoma
-
0:33
the unmet need of patients with poor-risk kidney cancer
-
9:35
novel therapies in renal cell carcinoma
-
7:16
adjuvant therapy in high-risk renal cell cancer
-
5:54
adjuvant sunitinib’s role in the treatment of rcc
-
59:55
renal cell carcinoma: past, present, and future
-
12:49
the tivo-3 study of tivozanib in metastatic renal cell carcinoma
-
1:46
clinical trials in kidney cancer to look out for
-
5:49
importance of risk assessment in renal cell carcinoma
-
3:49
adjuvant sunitinib for renal cell carcinoma
-
2:20
dr. mcgregor on advances made in the adjuvant setting of rcc
-
1:11
current standard of adjuvant therapy in kidney cancer
-
1:02
dr. voss on the case for neoadjuvant treatment in kidney cancer
-
0:51
novel immune therapeutics for adjuvant treatment of kidney cancer
-
4:57
review of the data of frontline treatment for non-clear cell kidney cancer
-
4:25
first-line therapy for renal cell carcinoma
-
3:43
risk stratification for metastatic renal cell carcinoma
-
4:43
nivolumab in renal cell carcinoma
-
6:44
novel agents in development for renal cell carcinoma
-
29:11
new data and clinical context: an update on renal cell carcinoma care
-
3:04
kidney cancer: minimizing toxicities and hassle in adjuvant therapy
-
2:23
s-trac phase iii trial of sunitinib as adjuvant therapy in high-risk renal cell cancer patients
-
0:42
unmet needs for patients with advanced rcc
-
1:21
dr. mckay discusses combinations in renal cell carcinoma
-
1:00
dr. paulson discusses unmet needs in the treatment of nets
-
0:55
selecting patients with renal cell carcinoma for adjuvant sunitinib therapy
-
4:16
treatment landscape of advanced clear cell rcc
-
7:34
frontline sunitinib compared to everolimus in metastatic renal cell carcinoma
-
8:43
immunotherapy in renal cell carcinoma
-
38:13
adjuvant therapy for advanced kidney cancer w/ dr. rana mckay & dr. karim bensalah | ep. 56
-
7:54
combination therapies in renal cell carcinoma
-
0:35
potential of immunotherapy for kidney cancer
-
31:49
adjuvant therapy for locally advanced renal cell carcinoma: status in 2018
-
6:17
in rcc, what is the optimal treatment for intermediate/poor-risk disease?
-
1:33:08
rethinking the care of renal cell carcinoma
-
25:09
kidney cancer highlights from esmo 2022
-
7:21
managing renal cell carcinoma progression
-
4:09
patient communication about adjuvant therapy for rcc
-
0:58
next steps for combination immunotherapies for rcc
-
1:02
non-clear cell sarcamatoid kidney cancer treatment updates
-
2:11
dr. haas on adjuvant sorafenib or sunitinib for rcc
-
4:33
radiation therapy in renal cell carcinoma
-
5:57
current landscape and future direction in systemic therapy for renal cell carcinoma (rcc)
-
8:16
prognostic and predictive factors in renal cell carcinoma
-
2:32
adjuvant therapy in rcc - dr. andre fay (english version)
-
3:13
renal cell carcinoma: early management strategies
-
5:50
first-line considerations in metastatic renal cell carcinoma
-
5:36
sequencing metastatic renal cell carcinoma treatments
-
8:31
bone and brain metastases in renal cell carcinoma
-
6:53
treatment of metastatic non-clear cell renal cell carcinoma
-
6:44
immune checkpoint inhibition in renal cell carcinoma
-
0:53
unanswered questions in the management of clear cell rcc
-
6:52
nivolumab in renal cell carcinoma
-
5:59
prosper rcc study of perioperative nivolumab for renal cell carcinoma - future trial
-
10:32
managing checkpoint inhibitor therapy in renal cell carcinoma
-
1:13
addressing concerns for neoadjuvant therapies in locally advanced kidney cancer
-
58:06
update on the management of localized renal tumors
-
11:33
latest in adjuvant therapy for renal cell carcinoma
-
8:31
second-line angiogenesis inhibition in metastatic renal cell carcinoma